Alejandro Comellas is a Respiratory physician affiliated with University of Iowa. OpenAlex indexes 414 publications with 7,242 citations (h-index 48).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Hawkins Dr
Iowa City, IA 522421009
Telephone
319-356-4187Registry record last updated 27 Jan 2010.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year20251 payment
- Genentech, Inc.Program year20251 payment
- GlaxoSmithKline, LLC.Program year202410 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
68%Corticosteroid35.1%Trelegy Ellipta51%Fluticasone Propionate21%Breo Ellipta18%Breztri Aerosphere10%Part D<11 patientsbeta2-Adrenergic Agonist15.5%Albuterol Sulfate Hfa100%Part D≥18 patients+ 2 more classes in this area
Anti-infectives
23.9%Macrolide Antimicrobial23.9%Azithromycin100%Part D<11 patientsMetabolism & gastrointestinal
8.1%Corticosteroid8.1%Prednisone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- : Osteoporosis and Sarcopenia in COPD and CT-based Phenotypes
University of Iowa
FY2026$116,625R21HL172227
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function
New England Journal of Medicine
2022 - Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine
2022 - Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID
International Journal of Environmental Research and Public Health
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Perlman, MD
University of Iowa
Mohammed Milhem, MBBS
University of Iowa
Lawrence Hunsicker, MD
University of Iowa
Michael Abramoff, MD, PhD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”